Related Experiment Video

Updated: Sep 28, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases

Nusrat Zahan Rouf1, Sumit Biswas2, Nawseen Tarannum3

  • 1School of Biological Sciences, Faculty of Biology, Medicine, & Health, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

RNA Biology
|March 31, 2022
PubMed

Insights

Messenger RNA (mRNA) vaccines offer a balanced immune response, overcoming past challenges. This technology, proven by COVID-19 vaccines, holds promise for future disease prevention.

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Messenger RNA (mRNA) vaccine technology has been researched for decades.
  • The COVID-19 pandemic accelerated attention and development of mRNA vaccines.
  • Traditional vaccines differ from mRNA vaccines in their immune response mechanisms.

Purpose of the Study:

  • To review the evolution and development of mRNA vaccine technology.
  • To address the challenges and skepticism surrounding mRNA vaccine adoption.
  • To explore the potential of mRNA vaccines for future prophylactic applications.

Main Methods:

  • Review of existing literature on mRNA vaccine development.
  • Analysis of the immune response elicited by mRNA vaccines.
  • Examination of challenges including stability, immunogenicity, and delivery.
  • Evaluation of safety, efficacy, and rapid development potential.

Main Results:

  • mRNA vaccines induce both humoral and cellular adaptive immunity.
  • Overcoming hurdles like stability and delivery is crucial for widespread adoption.
  • COVID-19 mRNA vaccines demonstrated feasibility, safety, and efficacy.
  • The platform shows potential for rapid development and deployment.

Conclusions:

  • mRNA vaccines represent a significant advancement in vaccinology.
  • The technology has overcome previous limitations and proven its value.
  • mRNA vaccines offer a promising platform for addressing infectious and other diseases.
Keywords:
COVID-19IVT-mRNAin vivo delivery of mRNAmRNA vaccinemRNA vaccine for infectious diseasenucleoside modified mRNAvaccine efficacyvaccine storage

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.4K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.3K

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
432
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
180
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.9K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
136